In a landmark move for international medical device regulation, the Medical Device Authority (MDA) and National Medical Products...

In a continued effort to strengthen the quality and efficiency of regulatory assessments, the National Pharmaceutical Regulatory Agency...

In its ongoing efforts to streamline pharmaceutical regulatory procedures and embrace digital transformation, the Central Drugs Standard...

In a world where healthcare innovation often outpaces regulations, one country is stepping forward to bridge that gap with confidence,...

As the digital health landscape continues to evolve rapidly, the Health Sciences Authority (HSA) released the Revision 2 (R2)  of its...

In a strategic move to become a global hub for healthcare innovation, the Department of Health (DH) has announced a detailed timetable...

The Health Sciences Authority (HSA) has announced the implementation of revised GN-21, which is set to take effect on 14 July 2025 . This...

As of 16 June 2025 , a significant new chapter begins for medical device regulation in Great Britain, marking the first major overhaul of...

The Thai Food and Drug Administration (FDA) has implemented significant revisions to its medical device import policies through...

Australians who depend on medical devices will soon benefit from significant enhancements in the way device-related safety issues are...

The Medical Device Rules, 2017 (MDR-2017) have been instrumental in ensuring the quality and safety of medical devices in India. However,...

The South African Health Products Regulatory Authority (SAHPRA) has made significant strides in enhancing its regulatory framework for...